Premium
Circulating interleukin‐15 and RANTES chemokine in Parkinson’s disease
Author(s) -
Rentzos M.,
Nikolaou C.,
Andreadou E.,
Paraskevas G. P.,
Rombos A.,
Zoga M.,
Tsoutsou A.,
Boufidou F.,
Kapaki E.,
Vassilopoulos D.
Publication year - 2007
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/j.1600-0404.2007.00894.x
Subject(s) - chemokine , parkinson's disease , immunology , medicine , neuroscience , disease , psychology , inflammation
Interleukin‐15 promotes T‐cell proliferation, induction of cytolytic effector cells including natural killer (NK) and cytotoxic cells and stimulates B‐cell to proliferate and secrete immunoglobulins. RANTES is a C‐C beta chemokine with strong chemoattractant activity for T lymphocytes and monocytes. Objectives – The objective of our study was to find out whether IL‐15 and RANTES are involved in the possible inflammatory reactions of PD. Patients and methods – We measured by immunoassay serum IL‐15 and RANTES levels in 41 patients with PD in comparison with serum levels in 19 healthy subjects age and sex‐matched. IL‐15 and RANTES levels were correlated with sex, age, disease duration. H‐Y stage and the UPDRS III score in all the studied groups and were also correlated with treatment status in PD patients. Results – The PD group presented with significantly increased RANTES levels as compared to the control group ( P = 0.0009). No difference was observed as regards IL‐15 levels. A strong and significant correlation between RANTES levels and UPDRS III score was observed in PD patients ( R s = 0.42, P = 0.007). Untreated patients had significantly higher RANTES levels as compared to the controls. Conclusions – Our findings may suggest a recruitment of activated monocytes, macrophages and T lymphocytes to sites of inflammation in the central nervous system of PD patients.